Detailed Information on Publication Record
2022
Oesophageal cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up
OBERMANNOVÁ, Radka, M. ALSINA, A. CERVANTES, T. LEONG, F. LORDICK et. al.Basic information
Original name
Oesophageal cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up
Authors
OBERMANNOVÁ, Radka (203 Czech Republic, guarantor, belonging to the institution), M. ALSINA, A. CERVANTES, T. LEONG, F. LORDICK, M. NILSSON, N. C. T. VAN GRIEKEN, A. VOGEL and E. C. SMYTH
Edition
Annals of Oncology, AMSTERDAM, Elsevier, 2022, 0923-7534
Other information
Language
English
Type of outcome
Článek v odborném periodiku
Field of Study
30204 Oncology
Country of publisher
Netherlands
Confidentiality degree
není předmětem státního či obchodního tajemství
References:
Impact factor
Impact factor: 50.500
RIV identification code
RIV/00216224:14110/22:00128842
Organization unit
Faculty of Medicine
UT WoS
000938788800003
Keywords in English
diagnosis; ESMO Clinical Practice Guideline; follow-up; oesophageal cancer; treatment
Tags
International impact, Reviewed
Změněno: 5/4/2023 08:44, Mgr. Tereza Miškechová
Abstract
V originále
This ESMO Clinical Practice Guideline provides key recommendations for managing oesophageal cancer. • The guideline covers clinical and pathological diagnosis, staging and risk assessment, treatment and follow-up. • Algorithms for the management of locoregional and advanced/metastatic disease are provided. • The author group encompasses a multidisciplinary group of experts from different institutions in Europe and Australia. • Recommendations are based on available scientific data and the authors’ collective expert opinion.